The results revealed that mouse melanomas with activated Nras, which can activate PI3K signaling, expressed higher levels of Tbx2 than those with the BrafV600E mutation, and that in both NrasQ61K or BrafV600E melanomas, loss of Pten increased Tbx2 expression (Fig. 1G). This evidence concerns the gene NRAS and melanoma.